Camp4 Therapeutics Corp (CAMP)
Camp4 Therapeutics Corp (CAMP) Insider Trading
Directors, officers and holders of more than 10% of CAMP report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 102 transactions on file: 15 with code P, 6 with code S and 29 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Gold Kelly | Chief Financial Officer | P Purchase | 10,000 | $3.96 | $39,600 |
| Aug 27, 2026 | Schwab Andrew J. | Director | S Sale | 400,000 | $4.04 | $1,616,000 |
| Aug 24, 2026 | Schwab Andrew J. | Director | S Sale | 10 | $4.50 | $45 |
| Aug 21, 2026 | Schwab Andrew J. | Director | S Sale | 32,018 | $4.50 | $144,081 |
| Aug 20, 2026 | Schwab Andrew J. | Director | S Sale | 114,700 | $4.54 | $520,738 |
| Aug 19, 2026 | Tardiff Daniel | Chief Scientific Officer | S Sale | 1,738 | $4.76 | $8,273 |
| Aug 19, 2026 | Schwab Andrew J. | Director | S Sale | 45,147 | $4.76 | $214,900 |
| Aug 3, 2026 | 5AM Partners VI, LLC | 10% Owner | P Purchase | 3,179,558 | $1.53 | $4,864,406 |
| Aug 3, 2026 | Gold Kelly | Chief Financial Officer | P Purchase | 6,551 | $1.65 | $10,809 |
| Aug 3, 2026 | Maricich Yuri | Chief Medical Officer | P Purchase | 6,551 | $1.65 | $10,809 |
| Aug 3, 2026 | Mandel-Brehm Josh | Chief Executive Officer | P Purchase | 6,551 | $1.65 | $10,809 |
| Aug 3, 2026 | Young Richard A | Director | P Purchase | 16,378 | $1.65 | $27,024 |
| Aug 3, 2026 | Schwab Andrew J. | Director | A Award | 3,179,558 | $1.53 | $4,864,406 |
| Jun 10, 2026 | Schwab Andrew J. | Director | A Award | 28,000 | Not measured | Not measured |
| Jun 10, 2026 | WILLIAMS DOUGLAS E | Director | A Award | 28,000 | Not measured | Not measured |
| Jun 10, 2026 | Nashat Amir | Director | A Award | 28,000 | Not measured | Not measured |
| Jun 10, 2026 | Young Richard A | Director | A Award | 28,000 | Not measured | Not measured |
| Jun 10, 2026 | Stewart Murray | Director | A Award | 28,000 | Not measured | Not measured |
| Jun 10, 2026 | Holtzman Steven H | Director | A Award | 28,000 | Not measured | Not measured |
| Apr 1, 2026 | Gold Kelly | Chief Financial Officer | A Award | 215,000 | Not measured | Not measured |
| Apr 1, 2026 | MacLean Michael F | Director | A Award | 56,000 | Not measured | Not measured |
| Apr 1, 2026 | Maricich Yuri | Chief Medical Officer | A Award | 215,000 | Not measured | Not measured |
| Apr 1, 2026 | Tardiff Daniel | Chief Scientific Officer | A Award | 170,000 | Not measured | Not measured |
| Apr 1, 2026 | Mandel-Brehm Josh | Chief Executive Officer | A Award | 580,000 | Not measured | Not measured |
| Dec 11, 2025 | Mandel-Brehm Josh | Chief Executive Officer | A Award | 425,000 | Not measured | Not measured |
| Dec 11, 2025 | Gold Kelly | Chief Financial Officer | A Award | 190,000 | Not measured | Not measured |
| Dec 11, 2025 | Tardiff Daniel | Chief Scientific Officer | A Award | 145,500 | Not measured | Not measured |
| Dec 11, 2025 | Maricich Yuri | Chief Medical Officer | A Award | 190,000 | Not measured | Not measured |
| Sep 11, 2025 | Mandel-Brehm Josh | Chief Executive Officer | P Purchase | 6,060 | $1.65 | $9,999 |
| Sep 11, 2025 | Nashat Amir | Director | P Purchase | 85,468 | $1.53 | $130,766 |
| Sep 11, 2025 | Nashat Amir | Director | P Purchase | 1,221,721 | $1.53 | $1,869,233 |
| Sep 11, 2025 | Schwab Andrew J. | Director | A Award | 2,941,176 | $1.53 | $4,499,999 |
| Sep 11, 2025 | Polaris Management Co. VII, L.L.C. | 10% Owner | P Purchase | 85,468 | $1.53 | $130,766 |
| Sep 11, 2025 | Polaris Management Co. VII, L.L.C. | 10% Owner | P Purchase | 1,221,721 | $1.53 | $1,869,233 |
| Sep 11, 2025 | Maricich Yuri | Chief Medical Officer | P Purchase | 6,060 | $1.65 | $9,999 |
| Sep 11, 2025 | Young Richard A | Director | P Purchase | 15,151 | $1.65 | $24,999 |
| Sep 11, 2025 | 5AM Partners VI, LLC | 10% Owner | P Purchase | 2,941,176 | $1.53 | $4,499,999 |
| Sep 11, 2025 | Gold Kelly | Chief Financial Officer | P Purchase | 6,060 | $1.65 | $9,999 |
| Jun 25, 2025 | Young Richard A | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 25, 2025 | Higgins Michael J | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 25, 2025 | Boylan James P | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 25, 2025 | Nashat Amir | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 25, 2025 | Holtzman Steven H | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 25, 2025 | Thadhani Ravi I. | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 25, 2025 | Schwab Andrew J. | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 25, 2025 | Ragan Paula | Director | A Award | 9,000 | Not measured | Not measured |
| Apr 1, 2025 | Mandel-Brehm Josh | Chief Executive Officer | A Award | 160,000 | Not measured | Not measured |
| Apr 1, 2025 | Bumcrot David | Chief Scientific Officer | A Award | 45,000 | Not measured | Not measured |
| Apr 1, 2025 | Gold Kelly | Chief Financial Officer | A Award | 80,000 | Not measured | Not measured |
| Apr 1, 2025 | Maricich Yuri | Chief Medical Officer | A Award | 80,000 | Not measured | Not measured |
The full Form 4 history is on the CAMP company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.